Hypothyroidism in older adults: A narrative review.

cardiovascular system central nervous system cognition elderly hypothyroidism levothyroxine review

Journal

Endocrine, metabolic & immune disorders drug targets
ISSN: 2212-3873
Titre abrégé: Endocr Metab Immune Disord Drug Targets
Pays: United Arab Emirates
ID NLM: 101269157

Informations de publication

Date de publication:
28 Aug 2023
Historique:
received: 20 11 2022
revised: 07 04 2023
accepted: 27 04 2023
medline: 29 8 2023
pubmed: 29 8 2023
entrez: 29 8 2023
Statut: aheadofprint

Résumé

The prevalence of hypothyroidism increases along with aging, resulting in one of the most common comorbidities among patients over 75 years. The leading causes of hypothyroidism in older adults are iatrogenic, Hashimoto's thyroiditis, and medications. The narrative review aimed to discuss the clinical characteristics of hypothyroidism in older adults and the impact of hormonal replacement therapy on survival rates. Thyroid function declines over time due to physiological changes in the thyroid stimulating hormone signaling, iodine absorption and metabolism, thyroid hormone metabolism, and activity at peripheral sites. A serum TSH value over the upper limit of the normal reference range is not necessarily attributable to hypothyroidism. However, an appropriate diagnostic work-up is required to rule out true hypothyroidism and discriminate the etiology (i.e., thyroid autoimmune diseases, iodine deficiency, drug-induced hypothyroidism). Levothyroxine treatment should be considered in cases of overt hypothyroidism. A complete risk-to-benefit assessment, particularly considering the overall health status, life expectancy, cognitive function, mood, and cardiovascular and neurological background, should be considered before treating subclinical hypothyroidism with more potential benefits in patients under 75 years old. Levothyroxine formulations facilitating hormone absorption and increasing compliance to long-term treatment should be preferred. TSH target should usually be set over 3 mIU/ml. Defining optimal diagnostic approaches and targeted therapeutic strategies should be considered in the personalized management of aged patients with hypothyroidism.

Identifiants

pubmed: 37641994
pii: EMIDDT-EPUB-134097
doi: 10.2174/1871530323666230828110153
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Vincenzo Fiore (V)

UOSD Diabetologia - Endocrinologia, ASL RM5, Rome, Italy.

Alessandra Barucca (A)

UOSD Diabetologia - Endocrinologia, ASL RM5, Rome, Italy.

S Barraco (S)

UOSD Diabetologia - Endocrinologia, ASL RM5, Rome, Italy.

Domenico Triggiani (D)

Interdisciplinary Department of Medicine, University of Bari A. Moro, Bari, Italy.

Giovanni Carbotta (G)

Interdisciplinary Department of Medicine, University of Bari A. Moro, Bari, Italy.

Vito Angelo Giagulli (VA)

Interdisciplinary Department of Medicine, University of Bari A. Moro, Bari, Italy.

Giuseppina Piazzolla (G)

Interdisciplinary Department of Medicine, University of Bari A. Moro, Bari, Italy.

Giuseppe Lisco (G)

UOSD Diabetologia - Endocrinologia, ASL RM5, Rome, Italy.

Vincenzo Triggiani (V)

Interdisciplinary Department of Medicine, University of Bari A. Moro, Bari, Italy.

Classifications MeSH